A STUDY OF SCREENING TESTS FOR PSYCHIATRIC SYMPTOMS IN DRUG USERS
Keywords:
Substance abuse, Psychiatric symptoms, Screening testsAbstract
Psychiatric problems from drug use are a common phenomenon in Thai society, which can be prevented and reduced by reducing the influence of risk factors. The purpose of this study was to study a screening test for the likelihood of psychiatric symptoms among drug users. A diagnostic test study design was used to test the screening tool among 880 drug users receiving treatment in a service center. Data were collected using the developed interview form. Data were analyzed using descriptive statistics, Chi-square, Confirmatory Factor Analysis, Intralass Correlation Coefficient, Cronbach Alpha Coefficient, and McDonald Omega Coefficient.
The tool has been constructed with seven prognostic variables, weighted and aggregated into scores. These properties underwent validation through known group validity testing. Confirmatory factor analysis revealed acceptable Construct Validity, supported by confidence values. The Omega Coefficient correlation is 0.89, with an inter-observer reliability of 0.96. The one-week test-retest yielded a value of 0.93. Sensitivity is recorded at 0.81, specificity at 0.72, positive predictive value at 0.78, negative predictive value at 0.74, and predictive validity at 0.76.
Downloads
References
United Nations Office on Drugs and Crime (UNODC). World drug report 2019. Vienna: United Nations publication; 2019.
Merlin MD. Archaeological evidence for the tradition of psychoactive plant use in the old world. Economic Botany 2003; 57(3): 295-323.
Sullivan RJ, Hagen EH. Psychotropic substance-seeking: Evolutionary pathology or adaptation? Addiction 2002; 97(4): 389-400.
Department of Fine Arts. The “Tra Sam Duang” Laws. Bangkok: Veteran printing house; 1978.
Kanato M, Leyatikul P, Wonguppa R. Impacts of Medical Cannabis Law in Thailand. ONCB Journal 2020; 36(2): 27-36.
Poshyachinda V. Heroin in Thailand. in the 4th Anniversary of the Office of the Narcotics Control Board. Bangkok: Office of the Prime Minister; 1980; 56–87.
Poshyachinda V, Srisurapanont M, Perngparn U. Amphetamine type stimulants epidemic in Thailand: a country profile. In WHO meeting on amphetamine, MDMA, and other psycho stimulants phase II. Bangkok, Thailand; 1999. 22-26.
Poshyachinda V, Phittayanon P, Simasatitkul V, Perngparn U. Stimulant use, abuse, and dependence in Thailand. Alcohol and drugs perspectives, prevention and control-Asia Pacific region. Sri Lanka: Alcohol and Drug Information Centre; 1998. 77-106.
Wonguppa R, Kanato M. The prevalence and associated factors of new psychoactive substance use: A 2016 Thailand national household survey. Addict Behav Rep 2018; 7: 111-115.
Kanato M, Leyatikul P, Wonguppa R. Cannabis Situation among the Thai Youth after Law Amendment. ONCB Journal 2022; 36(2): 27-36.
United Nations Office on Drugs and Crime (UNODC). World drug report 2023. Vienna: United Nations publication; 2023.
Kanato M, Sarasiri R, Leyatikul P, (Eds.) ASEAN DRUG MONITORING REPORT 2022. Bangkok: ASEAN Narcotics Cooperation Center; 2023.
Kanato M, Leyatikul P. Size Estimation of Substances Users Population in Thailand 2019. ONCB Journal 2020; 36(2): 37-48.
Office of Secretary of National Addiction treatment & Rehabilitation Committee, Ministry of Public Health. Statistics on Addiction Treatment & Rehabilitation [online] 2020 [cited 2024 March 7]. Available from: https://ncmc.moph.go.th/home/index/dash
WHO. Management of substance abuse [online] 2021 [cited 2021 Jan 21]. Available from: https://www. Who. int/substance_abuse/facts/ATS/en/
McCrady BS, Epstein EE. Addictions: A comprehensive guidebook. Oxford University Press; 2013.
Grant KM, LeVan TD, Wells SM, Li M, Stoltenberg SF, Gendelman HE, et al. Methamphetamine-associated psychosis. Journal of Neuroimmune Pharmacology 2012; 7(1): 113-139.
Reise SP. Yu J. Parameter recovery in the graded response model using MULTILOG. Journal of educational Measurement 1990; 27(2): 133-144.
Embretson SE, Reise SP. Item response theory. Psychology Press; 2013
Arkin CF, Wachtel MS. How many patients are necessary to assess test performance?. JAMA 1990; 263(2): 275-278.
Buderer NMF. Statistical methodology: I. Incorporating the prevalence of disease into the sample size calculation for sensitivity and specificity. Academic Emergency Medicine 1996; 3(9): 895-900.
Sudjai N. Sample size calculation for diagnostic test studies. J Med Health Sci 2020; 27(2): 167-182.
Kittirattanapaiboon P, Tantirangsee N, Chutha W, Tantiaree A, Kwansanit P, Assanangkornchai S. Prevalence of mental disorders and mental health problems: Thai national mental health surver 2013. J Ment Health Thai 2017; 25(1): 1-19.
Bagozzi RP. Assessing construct validity in personality research: Applications to measures of self-esteem. Journal of research in personality 1993; 27(1): 49-87.
Westen D, Rosenthal R. Quantifying construct validity: two simple measures. Journal of personality and social psychology 2003; 84(3): 608-618.
Jreskog KG, Srbom D. Lisrel 7 - A guide to the program and applications. Chicago: Scientific Software Inc; 1989.
Browne MW, Cudeck R. Alternative ways of assessing model fit. Sociological methods & research 1992; 21(2): 230-258.
Bentler PM. Comparative fit indexes in structural models. Psychological bulletin 1990;107(2): 238-246.
Tucker LR, Lewis C. A reliability coefficient for maximum likelihood factor analysis. Psychometrika 1973; 38(1): 1-10.
Hu LT, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural equation modeling: a multidisciplinary journal 1999; 6(1): 1-55.
Arunogiri S, Foulds JA, McKetin R, Lubman DI. A systematic review of risk factors for methamphetamine-associated psychosis. Australian & New Zealand Journal of Psychiatry 2018; 52(6): 514–529.
McKetin R, Leung J, Stockings E, Huo, Y, Foulds J, Lappin JM, et al. Mental health outcomes associated with the use of amphetamines: A systematic review and meta-analysis. EClinicalMedicine 2019;16: 81-97.
DiMiceli LE, Sherman SG, Aramrattana A, Sirirojn B, Celentano, DD. Methamphetamine use is associated with high levels of depressive symptoms in adolescents and young adults in Rural Chiang Mai Province, Thailand. BMC Public Health 2016; 16(1): 1-9.
McKetin R, Lubman DI, Baker AL, Dawe S, Ali RL. Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study. JAMA psychiatry 2013; 70(3): 319-324.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Community Health Development Quarterly Khon Kaen University
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles in this journal are copyrighted by the x may be read and used for academic purposes, such as teaching, research, or citation, with proper credit given to the author and the journal.use or modification of the articles is prohibited without permission.
statements expressed in the articles are solely the opinions of the authors.
authors are fully responsible for the content and accuracy of their articles.
other reuse or republication requires permission from the journal."
